LSD1 anticorps (AA 140-190)
Aperçu rapide pour LSD1 anticorps (AA 140-190) (ABIN6990620)
Antigène
Voir toutes LSD1 (KDM1A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 140-190
-
Purification
- LSD1 Antibody is affinity chromatography purified via peptide column.
-
Immunogène
- Anti-LSD1 antibody was raised against a peptide corresponding to 16 amino acids near the center of human LSD1. The immunogen is located within amino acids 140-190 of LSD1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 0.2 - 2 μ,g/mL, IHC-P: 2 μ,g/mL, IF: 20 μ,g/mL
Antibody validated: Western Blot in human, mouse and rat samples, Immunohistochemistry and Immunofluorescence in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- LSD1 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- LSD1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- LSD1 (KDM1A) (Lysine (K)-Specific Demethylase 1A (KDM1A))
-
Autre désignation
- LSD1
-
Sujet
- LSD1 Antibody: Histone modifications mediate changes in gene expression by altering chromatin structure or by serving as a platform to recruit other proteins. LSD1 is a recently discovered amine oxidase that catalyzes the lysine-specific demethylation of histone proteins via an FAD-dependent oxidative reaction. Methylation on histone H3-K9 is thought to play an important role in heterochromatin formation, while methylation on arginine and some lysine residues (such as H3-K4) is associated with active transcription. LSD1 associates with various proteins, including HDAC1/2, CoREST, and BHC80, that act to regulate LSD1 activity in vivo, and in a histone H3-K4-specific methylase complex that is involved in transcriptional regulation. Experiments have shown that CoREST, a SANT domain-containing corepressor acts to enhance LSD1 activity, while BHC80, a PHD domain-containing protein, inhibits CoREST/LSD1 activity in vitro. LSD1-mediated histone demethylation thus may have significant effects on gene expression.
-
Poids moléculaire
-
Predicted: 93kD
Observed: 110 kD kDa -
ID gène
- 23028
-
NCBI Accession
- NP_001009999
-
UniProt
- O60341
-
Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Negative Regulation of intrinsic apoptotic Signaling, L'effet Warburg
Antigène
-